However, the relative role of apoC-III's distribution on lipoproteins remains uncertain [19], and preliminary evidence suggests that obesity may play a central role in determining apoC-III levels, lipoprotein distribution, and clinical outcomes [20]. This evidence concerns the gene APOC3 and obesity due to melanocortin 4 receptor deficiency.